300 filings
PRE 14A
SCPH
scPharmaceuticals Inc
12 Apr 24
Preliminary proxy
4:14pm
SC 13G/A
SCPH
scPharmaceuticals Inc
5 Apr 24
scPharmaceuticals / BlackRock ownership change
12:21pm
4
SCPH
scPharmaceuticals Inc
2 Apr 24
scPharmaceuticals / John H Tucker ownership change
4:15pm
EFFECT
SCPH
scPharmaceuticals Inc
25 Mar 24
Notice of effectiveness
12:15am
424B5
SCPH
scPharmaceuticals Inc
22 Mar 24
Prospectus supplement for primary offering
4:48pm
S-8
SCPH
scPharmaceuticals Inc
13 Mar 24
Registration of securities for employees
4:58pm
S-3
SCPH
scPharmaceuticals Inc
Shelf registration
13 Mar 24
4:49pm
10-K
2023 FY
SCPH
scPharmaceuticals Inc
Annual report
13 Mar 24
4:16pm
8-K
SCPH
scPharmaceuticals Inc
13 Mar 24
Generated full-year net FUROSCIX® revenue of $13.6 million, at the upper end of the range provided in January
4:08pm
SC 13G/A
SCPH
scPharmaceuticals Inc
14 Feb 24
scPharmaceuticals / 5AM Ventures IV ownership change
4:25pm
SC 13G/A
Armistice Capital, LLC
14 Feb 24
scPharmaceuticals / ARMISTICE CAPITAL ownership change
2:56pm
SC 13G
Rubric Capital Management LP
12 Feb 24
scPharmaceuticals / Rubric Capital Management ownership change
6:06am
SC 13G/A
Hirschman Orin
7 Feb 24
scPharmaceuticals / HIRSCHMAN ORIN ownership change
6:55pm
SC 13G
SCPH
scPharmaceuticals Inc
2 Feb 24
scPharmaceuticals / BlackRock ownership change
3:57pm
SC 13G/A
Cowen Financial Products LLC
2 Feb 24
scPharmaceuticals / Cowen Financial Products ownership change
12:35pm
4
Rachael Nokes
22 Jan 24
scPharmaceuticals / Rachael Nokes ownership change
8:28pm
4
SCPH
scPharmaceuticals Inc
22 Jan 24
scPharmaceuticals / John H Tucker ownership change
8:27pm
SC 13G/A
SCPH
scPharmaceuticals Inc
12 Jan 24
scPharmaceuticals / MILLENNIUM MANAGEMENT ownership change
4:16pm
8-K
SCPH
scPharmaceuticals Inc
4 Jan 24
Gross-to-net (GTN) discount of approximately 18% from launch through the end of Q4
5:30pm
4
Rachael Nokes
3 Jan 24
scPharmaceuticals / Rachael Nokes ownership change
4:48pm